Foundayo vs Wegovy: the real difference
Two FDA-approved GLP-1 medications from different makers, one an oral pill, one best known as a weekly injection. Here is how they compare on molecule, form, and honest cash-pay price.
Foundayo (orforglipron) is Eli Lilly's once-daily oral non-peptide GLP-1, FDA-approved in April 2026, with no injection and no refrigeration. Wegovy (semaglutide) is Novo Nordisk's GLP-1, sold as a weekly injection and as an oral pill. Both are FDA-approved, not compounded. Sample cash-pay pricing starts near $149/month for each at the lowest dose; confirm current terms on the provider's site.
Every price read from the provider's own page and linked to its source, most recently Aug 1, 2026. On 8 of 30 listings the provider doesn't publish enough to know the real monthly cost, so we say so rather than guess. Prices change often; confirm at checkout before buying. How we verify.
| Attribute | Foundayo | Wegovy |
|---|---|---|
| Molecule | Orforglipron (non-peptide GLP-1) | Semaglutide (GLP-1) |
| Maker | Eli Lilly | Novo Nordisk |
| Form | Oral pill, once daily | Weekly injection + oral pill |
| Refrigeration | Not required | Injectable refrigerated; oral pill not |
| FDA status | FDA-approved (Apr 2026) | FDA-approved |
| Lowest sample cash price | $149/mo (LillyDirect) | $149/mo oral · $349/mo injectable (NovoCare) |
How they actually differ
Foundayo and Wegovy are different GLP-1 medications from different makers. Foundayo is the brand name for orforglipron, a non-peptide oral GLP-1 from Eli Lilly, FDA-approved in April 2026. Wegovy is the brand name for semaglutide from Novo Nordisk, known as a once-weekly injection and also available as an oral pill. Because both names get searched together, this page compares Foundayo against both forms of Wegovy.
The clearest split is form and routine. Foundayo is a once-daily tablet that needs no injection and no refrigeration. Wegovy is best known as a weekly self-injection, though Novo Nordisk also offers an oral semaglutide version. If avoiding needles or skipping the fridge matters to you, that is the practical difference to weigh. Both are FDA-approved prescription products, so neither carries the compounded, not-FDA-approved label.
On price, our source-verified pricing shows cash-pay options starting near $149 per month for each at their lowest dose through manufacturer-direct channels, with Foundayo escalating toward roughly $349/month at higher doses and the branded Wegovy injectable around $349/month. These figures are read from each provider's own site and timestamped, not a quote or guarantee. Confirm the current price, dose tiers, and renewal terms on the provider's own checkout before deciding. Pep Recs does not sell or prescribe medication, and nothing here is medical advice; talk to a licensed clinician.
Common questions
What is the difference between Foundayo and Wegovy?
Foundayo (orforglipron) is Eli Lilly's once-daily oral non-peptide GLP-1, FDA-approved in April 2026, with no injection and no refrigeration. Wegovy (semaglutide) is Novo Nordisk's GLP-1, available as a once-weekly injection and as an oral pill. Both are FDA-approved, not compounded. The main practical differences are the maker, the molecule, and that Foundayo is pill-only while Wegovy is best known as an injectable.
Is Foundayo better than Wegovy?
Neither is universally better; they are different molecules from different makers, and the right choice depends on your situation. Foundayo is a once-daily pill with no injection or refrigeration, while Wegovy is offered as a weekly injection and as an oral pill. Both are FDA-approved. A licensed clinician is the right person to compare them for you. Pep Recs does not provide medical advice.
Is Foundayo a pill or an injection?
Foundayo (orforglipron) is an oral pill taken once daily. It is a non-peptide oral GLP-1 and requires no injection and no refrigeration. By contrast, Wegovy is best known as a once-weekly injection, though Novo Nordisk also sells an oral semaglutide version of Wegovy.
How much does Foundayo cost vs Wegovy?
Our source-verified pricing shows Foundayo (orforglipron) starting near $149 per month at its lowest dose via LillyDirect, escalating toward roughly $349 per month at higher doses. Sample cash-pay pricing for Wegovy starts near $149 per month for the oral version via NovoCare, with the branded injectable around $349 per month. These figures are timestamped and read from each provider's own site, not a quote or guarantee; confirm current pricing and terms on the provider's site at checkout.
Is Foundayo FDA-approved?
Yes. Foundayo (orforglipron) was FDA-approved in April 2026 and is sold cash-pay direct from the manufacturer, Eli Lilly. Wegovy (semaglutide) is also FDA-approved. Neither product is a compounded, not-FDA-approved medication.
Can you switch from Wegovy to Foundayo?
Whether to switch from one GLP-1 to another is a medical decision that should be made with a licensed clinician who knows your history. Pep Recs does not sell, prescribe, or recommend medication, and nothing here is medical advice. We provide price, form, and regulatory-status facts so you can have an informed conversation with your prescriber.
New to the FDA-approved vs compounded distinction? Read the explainer →